Extended and New Partnerships, and Upcoming Conferences - Analyst Notes on Perrigo, Intuitive Surgical, Aetna, St Jude Medical, and Stryker

News provided by

Mar 26, 2014, 08:00 ET

Editor Note: For more information about this release, please scroll to bottom, March 26, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Perrigo Company (NYSE: PRGO), Intuitive Surgical, Inc. (NASDAQ: ISRG), Aetna Inc. (NYSE: AET), St. Jude Medical, Inc. (NYSE: STJ), and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Perrigo Company Analyst Notes

On March 13, 2014, Perrigo Company (Perrigo) announced that PetArmor®, a brand of Sergeant's Pet Care Products, Inc., will continue its partnership with Vested Interest in K9s, Inc. - a nonprofit organization dedicated to providing bullet-and-stab protective vests to police organizations in the US. Commenting on the news, Caryn Stichler, VP of Marketing for Sergeant's Pet Care Products, remarked, "PetArmor has developed a partnership with Vested Interest in K9s because the companies share a common value: making canine protection our No. 1 focus. K-9s put their lives on the line every day to help protect us and keep our communities safe. Helping to protect them through this donation is our way of saying thank you." The full analyst notes on Perrigo Company are available to download free of charge at:

http://www.AnalystsReview.com/03262014/PRGO/report.pdf

Intuitive Surgical, Inc. Analyst Notes

On March 20, 2014, Intuitive Surgical, Inc. (Intuitive Surgical) has scheduled its quarterly conference call to discuss its Q1 2014 to be on Tuesday, April 22, 2014 at 4:30 p.m. ET. Interested parties may access the call via the Company's website. The full analyst notes on Intuitive Surgical, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03262014/ISRG/report.pdf

Aetna Inc. Analyst Notes

On March 17, 2014, Aetna Inc. (Aetna) announced that HR Policy Association has chosen the Company to create the next generation of its highly successful Retiree Health Access (RHA) program. In order to do this, Aetna has formed collaborations with eHealth, one of the leading online enrollment platforms for individual health insurance; and Benefitfocus wherein Benefitfocus HR INTOUCH MARKETPLACE® helps retirees in RHA plans shop for and enroll in the benefits that best fit their individual needs. RHA also will feature a number of innovative tools from Aetna such as iTriage, which can help members understand their symptoms, find medical care and even make appointments from the convenience of a smartphone; and CarePass®, a consumer website and mobile solution that offers convenient and connected access to some of the best health and wellness mobile apps - to give retirees and their family members ongoing support to navigate the health care system regardless of which carrier or coverage option they choose. The full analyst notes on Aetna Inc are available to download free of charge at:

http://www.AnalystsReview.com/03262014/AET/report.pdf

St. Jude Medical, Inc. Analyst Notes

On March 20, 2014, St. Jude Medical, Inc. (St. Jude Medical) announced the CE Mark approval and European launch of its Prodigy™ Chronic Pain System with Burst Technology. According to St. Jude Medical, the Prodigy™ system is the first and only implantable neuromodulation system that delivers burst stimulation. Prodigy is designed to reduce pain, improve patient satisfaction and allow reduced paresthesia (a tingling sensation associated with stimulation), and it offers patients traditional tonic spinal cord stimulation (SCS) in addition to Burst Technology for improved stimulation options. Commenting on the news, Eric S. Fain, M.D., Group President of St. Jude Medical stated, "The Prodigy system is a great example of our approach for innovative and alternative ways to provide relief to patients suffering from chronic pain, including those who have exhausted other treatment options or who may have lost effective therapy using traditional tonic stimulation. In addition to our recent investment in Spinal Modulation, the Prodigy neurostimulator showcases our continued commitment to expanding the neuromodulation program for St. Jude Medical and focusing on improved outcomes for patients." The full analyst notes on St. Jude Medical, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03262014/STJ/report.pdf

Stryker Corporation Analyst Notes

On March 17, 2014, Stryker Corporation (Stryker) announced that it will hold its 2014 Annual Meeting of Shareholders on April 22, 2014 at 2:00 p.m. ET at the Radisson Plaza Hotel & Suites at the Kalamazoo Center in Kalamazoo, Michigan. Interested parties can access the live meeting by calling 888-771-4371 (U.S.) or 847-585-4405 (International) and entering passcode 36762234. An archived copy of the meeting will also be available from 4:30 p.m. ET on Tuesday, April 22, 2014 through 11:59 p.m. ET on Thursday, May 22, 2014. An archived copy of the webcast will continue to be available on Stryker's website until June 30, 2014. The full analyst notes on Stryker Corporation are available to download free of charge at:

http://www.AnalystsReview.com/03262014/SYK/report.pdf

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES:

This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review